{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T20:45:55Z","timestamp":1776717955279,"version":"3.51.2"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:00:00Z","timestamp":1726704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:00:00Z","timestamp":1726704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-024-08455-5","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T09:02:13Z","timestamp":1726736533000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effectiveness of long-term low-dose aspirin in the prevention of gastric cancer after Helicobacter pylori eradication: study design and rationale of Ardabil gastric cancer randomized placebo-controlled prevention trial (AGCPT)"],"prefix":"10.1186","volume":"25","author":[{"given":"Farhad","family":"Pourfarzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad-Mahdi","family":"Rashidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas","family":"Yazdanbod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Nemati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadi Peeri","family":"Dogaheh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elnaz","family":"Faghfuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fateme","family":"Gorgani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saied","family":"Hosseini-Asl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bijan","family":"Zamani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanaz","family":"Pourfarzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arash","family":"Etemadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fateme","family":"Shafighian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Negar","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Poustchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Malekzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Sadjadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,19]]},"reference":[{"issue":"3","key":"8455_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"8455_CR2","volume-title":"Global cancer observatory: cancer today","author":"JEM Ferlay","year":"2020","unstructured":"Ferlay JEM, Lam F, Colombet M, Mery L, Pi\u00f1eros M, Znaor A, Soerjomataram I, Bray F. Global cancer observatory: cancer today. Lyon: International Agency for Research on Cancer; 2020.\u00a0Available from:\u00a0https:\/\/gco.iarc.fr\/today.\u00a0Accessed 10 Oct 2021."},{"issue":"7","key":"8455_CR3","doi-asserted-by":"publisher","first-page":"556","DOI":"10.34172\/aim.2021.79","volume":"24","author":"E Akbarpour","year":"2021","unstructured":"Akbarpour E, Sadjadi A, Derakhshan M, Roshandel G, Alimohammadian M. Gastric cancer in Iran: an overview of risk factors and preventive measures. Arch Iran Med. 2021;24(7):556\u201367.","journal-title":"Arch Iran Med"},{"key":"8455_CR4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.canep.2019.05.009","volume":"61","author":"G Roshandel","year":"2019","unstructured":"Roshandel G, Ghanbari-Motlagh A, Partovipour E, Salavati F, Hasanpour-Heidari S, Mohammadi G, et al. Cancer incidence in Iran in 2014: results of the Iranian National Population-based Cancer Registry. Cancer Epidemiol. 2019;61:50\u20138.","journal-title":"Cancer Epidemiol"},{"issue":"12","key":"8455_CR5","first-page":"0-","volume":"15","author":"K Zendehdel","year":"2012","unstructured":"Zendehdel K, Marzban M, Nahvijou A, Jafari N. Six-fold difference in the stomach cancer mortality rate between northern and southern Iran. Arch Iran Med. 2012;15(12):0-.","journal-title":"Arch Iran Med"},{"issue":"6","key":"8455_CR6","doi-asserted-by":"publisher","first-page":"695","DOI":"10.21147\/j.issn.1000-9604.2020.06.03","volume":"32","author":"L Yang","year":"2020","unstructured":"Yang L, Ying X, Liu S, Lyu G, Xu Z, Zhang X, et al. Gastric cancer: epidemiology, risk factors and prevention strategies. Chin J Cancer Res. 2020;32(6):695\u2013704.","journal-title":"Chin J Cancer Res"},{"issue":"4","key":"8455_CR7","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1053\/j.gastro.2020.11.017","volume":"160","author":"MB Piazuelo","year":"2021","unstructured":"Piazuelo MB, Bravo LE, Mera RM, Camargo MC, Bravo JC, Delgado AG, et al. The Colombian chemoprevention trial: 20-year follow-up of a cohort of patients with gastric precancerous lesions. Gastroenterology. 2021;160(4):1106-17.e3.","journal-title":"Gastroenterology"},{"issue":"2","key":"8455_CR8","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1001\/jama.291.2.187","volume":"291","author":"BC Wong","year":"2004","unstructured":"Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA. 2004;291(2):187\u201394.","journal-title":"JAMA"},{"key":"8455_CR9","doi-asserted-by":"publisher","first-page":"101741","DOI":"10.1016\/j.bpg.2021.101741","volume":"50","author":"T Weltermann","year":"2021","unstructured":"Weltermann T, Schulz C, Macke L. Effect of frequently prescribed drugs on gastric cancer risk. Best Pract Res Clin Gastroenterol. 2021;50:101741.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"2","key":"8455_CR10","doi-asserted-by":"publisher","first-page":"191","DOI":"10.15403\/jgld-818","volume":"29","author":"TT Win","year":"2020","unstructured":"Win TT, Fern JLC, Fei CO. Aspirin and reducing risk of gastric cancer: systematic review and meta-analysis of the observational studies. J Gastrointestin Liver Dis. 2020;29(2):191.","journal-title":"J Gastrointestin Liver Dis"},{"issue":"2","key":"8455_CR11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/jgh3.12226","volume":"4","author":"R Niikura","year":"2020","unstructured":"Niikura R, Hirata Y, Hayakawa Y, Kawahara T, Yamada A, Koike K. Effect of aspirin use on gastric cancer incidence and survival: a systematic review and meta-analysis. Jgh Open. 2020;4(2):117\u201325.","journal-title":"Jgh Open"},{"issue":"3","key":"8455_CR12","doi-asserted-by":"publisher","first-page":"4781","DOI":"10.18632\/oncotarget.13591","volume":"8","author":"XZ Huang","year":"2017","unstructured":"Huang XZ, Chen Y, Wu J, Zhang X, Wu CC, Zhang CY, et al. Aspirin and non-steroidal anti-inflammatory drugs use reduce gastric cancer risk: a dose-response meta-analysis. Oncotarget. 2017;8(3):4781.","journal-title":"Oncotarget"},{"issue":"15","key":"8455_CR13","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.7150\/jca.16524","volume":"7","author":"P Kong","year":"2016","unstructured":"Kong P, Wu R, Liu X, Liu J, Chen S, Ye M, et al. The effects of anti-inflammatory drug treatment in gastric cancer prevention: an update of a meta-analysis. J Cancer. 2016;7(15):2247.","journal-title":"J Cancer"},{"issue":"7","key":"8455_CR14","doi-asserted-by":"publisher","first-page":"e71522","DOI":"10.1371\/journal.pone.0071522","volume":"8","author":"X Ye","year":"2013","unstructured":"Ye X, Fu J, Yang Y, Gao Y, Liu L, Chen S. Frequency-risk and duration-risk relationships between aspirin use and gastric cancer: a systematic review and meta-analysis. PLoS ONE. 2013;8(7): e71522.","journal-title":"PLoS One"},{"issue":"5","key":"8455_CR15","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/S1470-2045(12)70112-2","volume":"13","author":"AM Algra","year":"2012","unstructured":"Algra AM, Rothwell PM. Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials. Lancet Oncol. 2012;13(5):518\u201327.","journal-title":"Lancet Oncol"},{"issue":"6","key":"8455_CR16","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1007\/s10620-009-0915-0","volume":"55","author":"P Yang","year":"2010","unstructured":"Yang P, Zhou Y, Chen B, Wan HW, Jia GQ, Bai HL, et al. Aspirin use and the risk of gastric cancer: a meta-analysis. Dig Dis Sci. 2010;55(6):1533\u20139.","journal-title":"Dig Dis Sci"},{"issue":"4","key":"8455_CR17","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1097\/CEJ.0b013e328339648c","volume":"19","author":"W Tian","year":"2010","unstructured":"Tian W, Zhao Y, Liu S, Li X. Meta-analysis on the relationship between nonsteroidal anti-inflammatory drug use and gastric cancer. Eur J Cancer Prev. 2010;19(4):288\u201398.","journal-title":"Eur J Cancer Prev"},{"issue":"3","key":"8455_CR18","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/sj.bjc.6604880","volume":"100","author":"C Abnet","year":"2009","unstructured":"Abnet C, Freedman N, Kamangar F, Leitzmann M, Hollenbeck A, Schatzkin A. Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis. Br J Cancer. 2009;100(3):551\u20137.","journal-title":"Br J Cancer"},{"issue":"23","key":"8455_CR19","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1093\/jnci\/djg106","volume":"95","author":"WH Wang","year":"2003","unstructured":"Wang WH, Huang JQ, Zheng GF, Lam SK, Karlberg J, Wong BCY. Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis. J Natl Cancer Inst. 2003;95(23):1784\u201391.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"8455_CR20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1136\/jcp.57.1.37","volume":"57","author":"R Malekzadeh","year":"2004","unstructured":"Malekzadeh R, Sotoudeh M, Derakhshan M, Mikaeli J, Yazdanbod A, Merat S, et al. Prevalence of gastric precancerous lesions in Ardabil, a high incidence province for gastric adenocarcinoma in the northwest of Iran. J Clin Pathol. 2004;57(1):37\u201342.","journal-title":"J Clin Pathol"},{"issue":"4","key":"8455_CR21","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1093\/aje\/kwx314","volume":"187","author":"H Poustchi","year":"2018","unstructured":"Poustchi H, Eghtesad S, Kamangar F, Etemadi A, Keshtkar AA, Hekmatdoost A, et al. Prospective epidemiological research studies in Iran (the PERSIAN cohort study): rationale, objectives, and design. Am J Epidemiol. 2018;187(4):647\u201355.","journal-title":"Am J Epidemiol"},{"key":"8455_CR22","doi-asserted-by":"publisher","unstructured":"Lu L, Mullins CS, Schafmayer C, Zei\u00dfig S, Linnebacher M. A global assessment of recent trends in gastrointestinal cancer and lifestyle-associated risk factors. Cancer Commun (Lond). 2021;41(11):1137\u201351. https:\/\/doi.org\/10.1002\/cac2.12220.","DOI":"10.1002\/cac2.12220"},{"issue":"21","key":"8455_CR23","doi-asserted-by":"publisher","first-page":"13371","DOI":"10.1073\/pnas.222543099","volume":"99","author":"TD Warner","year":"2002","unstructured":"Warner TD, Mitchell JA. Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum? Proc Natl Acad Sci. 2002;99(21):13371\u20133.","journal-title":"Proc Natl Acad Sci"},{"issue":"10","key":"8455_CR24","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1016\/j.jacc.2019.03.010","volume":"74","author":"DK Arnett","year":"2019","unstructured":"Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;74(10):e177\u2013232.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"8455_CR25","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.jacc.2014.03.049","volume":"64","author":"S Halvorsen","year":"2014","unstructured":"Halvorsen S, Andreotti F, ten Berg JM, Cattaneo M, Coccheri S, Marchioli R, et al. Aspirin therapy in primary cardiovascular disease prevention: a position paper of the European Society of Cardiology working group on thrombosis. J Am Coll Cardiol. 2014;64(3):319\u201327.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"8455_CR26","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1093\/annonc\/mdu225","volume":"26","author":"J Cuzick","year":"2015","unstructured":"Cuzick J, Thorat M, Bosetti C, Brown P, Burn J, Cook N, et al. Estimates of benefits and harms of prophylactic use of aspirin in the general population. Ann Oncol. 2015;26(1):47\u201357.","journal-title":"Ann Oncol"},{"issue":"5\u20136","key":"8455_CR27","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0049-3848(03)00379-7","volume":"110","author":"J Vane","year":"2003","unstructured":"Vane J, Botting R. The mechanism of action of aspirin. Thromb Res. 2003;110(5\u20136):255\u20138.","journal-title":"Thromb Res"},{"issue":"7","key":"8455_CR28","first-page":"1276","volume":"57","author":"A Ristim\u00e4ki","year":"1997","unstructured":"Ristim\u00e4ki A, Honkanen N, J\u00e4nk\u00e4l\u00e4 H, Sipponen P, H\u00e4rk\u00f6nen M. Expression of cyclooxygenase-2 in human gastric carcinoma. Can Res. 1997;57(7):1276\u201380.","journal-title":"Can Res"},{"issue":"4","key":"8455_CR29","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/0016-5085(94)90246-1","volume":"107","author":"CE Eberhart","year":"1994","unstructured":"Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, Dubois RN. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology. 1994;107(4):1183\u20138.","journal-title":"Gastroenterology"},{"issue":"3","key":"8455_CR30","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S0016-5085(00)70254-X","volume":"118","author":"VN Shirvani","year":"2000","unstructured":"Shirvani VN, Ouatu-Lascar R, Kaur BS, Omary MB, Triadafilopoulos G. Cyclooxygenase 2 expression in Barrett\u2019s esophagus and adenocarcinoma: ex vivo induction by bile salts and acid exposure. Gastroenterology. 2000;118(3):487\u201396.","journal-title":"Gastroenterology"},{"issue":"1","key":"8455_CR31","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1006\/excr.1996.0023","volume":"222","author":"SJ Shiff","year":"1996","unstructured":"Shiff SJ, Koutsos MI, Qiao L, Rigas B. Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis. Exp Cell Res. 1996;222(1):179\u201388.","journal-title":"Exp Cell Res"},{"issue":"7","key":"8455_CR32","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0753-3322(00)88503-0","volume":"53","author":"B Wong","year":"1999","unstructured":"Wong B, Zhu G, Lam S. Aspirin induced apoptosis in gastric cancer cells. Biomed Pharmacother. 1999;53(7):315\u20138.","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"8455_CR33","first-page":"1469","volume":"79","author":"H Sawaoka","year":"1999","unstructured":"Sawaoka H, Tsuji S, Tsujii M, Gunawan ES, Sasaki Y, Kawano S, et al. Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo. Lab Invest. 1999;79(12):1469\u201377.","journal-title":"Lab Invest"},{"issue":"7","key":"8455_CR34","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1080\/07853890310017053","volume":"35","author":"C R\u00fcegg","year":"2003","unstructured":"R\u00fcegg C, Zaric J, Stupp R. Non steroidal anti-inflammatory drugs and COX-2 inhibitors as anti-cancer therapeutics: hypes, hopes and reality. Ann Med. 2003;35(7):476\u201387.","journal-title":"Ann Med"},{"issue":"4","key":"8455_CR35","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/S1674-8301(11)60033-X","volume":"25","author":"L Yang","year":"2011","unstructured":"Yang L, Zhu H, Liu D, Liang S, Xu H, Chen J, et al. Aspirin suppresses growth of human gastric carcinoma cell by inhibiting survivin expression. J Biomed Res. 2011;25(4):246\u201353.","journal-title":"J Biomed Res"},{"issue":"2","key":"8455_CR36","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1158\/1940-6207.CAPR-11-0391","volume":"5","author":"AT Chan","year":"2012","unstructured":"Chan AT, Arber N, Burn J, Chia WK, Elwood P, Hull MA, et al. Aspirin in the chemoprevention of colorectal neoplasia: an overview. Cancer Prev Res. 2012;5(2):164\u201378.","journal-title":"Cancer Prev Res"},{"issue":"3","key":"8455_CR37","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/nrc.2016.4","volume":"16","author":"DA Drew","year":"2016","unstructured":"Drew DA, Cao Y, Chan AT. Aspirin and colorectal cancer: the promise of precision chemoprevention. Nat Rev Cancer. 2016;16(3):173.","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"8455_CR38","doi-asserted-by":"publisher","first-page":"836","DOI":"10.7326\/M16-0577","volume":"164","author":"K Bibbins-Domingo","year":"2016","unstructured":"Bibbins-Domingo K. Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2016;164(12):836\u201345.","journal-title":"Ann Intern Med"},{"issue":"9754","key":"8455_CR39","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/S0140-6736(10)61543-7","volume":"376","author":"PM Rothwell","year":"2010","unstructured":"Rothwell PM, Wilson M, Elwin CE, Norrving B, Algra A, Warlow CP, et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet. 2010;376(9754):1741\u201350.","journal-title":"Lancet"},{"issue":"2","key":"8455_CR40","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.ygyno.2015.12.009","volume":"140","author":"F Verdoodt","year":"2016","unstructured":"Verdoodt F, Friis S, Dehlendorff C, Albieri V, Kjaer SK. Non-steroidal anti-inflammatory drug use and risk of endometrial cancer: a systematic review and meta-analysis of observational studies. Gynecol Oncol. 2016;140(2):352\u20138.","journal-title":"Gynecol Oncol"},{"issue":"6","key":"8455_CR41","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1093\/annonc\/mds113","volume":"23","author":"C Bosetti","year":"2012","unstructured":"Bosetti C, Rosato V, Gallus S, Cuzick J, La Vecchia C. Aspirin and cancer risk: a quantitative review to 2011. Ann Oncol. 2012;23(6):1403\u201315.","journal-title":"Ann Oncol"},{"issue":"5","key":"8455_CR42","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.annonc.2020.02.012","volume":"31","author":"C Bosetti","year":"2020","unstructured":"Bosetti C, Santucci C, Gallus S, Martinetti M, La Vecchia C. Aspirin and the risk of colorectal and other digestive tract cancers: an updated meta-analysis through 2019. Ann Oncol. 2020;31(5):558\u201368.","journal-title":"Ann Oncol"},{"issue":"2","key":"8455_CR43","first-page":"97","volume":"7","author":"DC Farrow","year":"1998","unstructured":"Farrow DC, Vaughan TL, Hansten PD, Stanford JL, Risch HA, Gammon MD, et al. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev. 1998;7(2):97\u2013102.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7250","key":"8455_CR44","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1136\/bmj.320.7250.1642","volume":"320","author":"M Langman","year":"2000","unstructured":"Langman M, Cheng K, Gilman E, Lancashire R. Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database. BMJ. 2000;320(7250):1642\u20136.","journal-title":"BMJ"},{"issue":"7","key":"8455_CR45","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1054\/bjoc.2001.1702","volume":"84","author":"K Akre","year":"2001","unstructured":"Akre K, Ekstr\u00f6m A, Signorello L, Hansson L, Nyren O. Aspirin and risk for gastric cancer: a population-based case\u2013control study in Sweden. Br J Cancer. 2001;84(7):965\u20138.","journal-title":"Br J Cancer"},{"issue":"1","key":"8455_CR46","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1158\/1055-9965.EPI-07-0664","volume":"17","author":"L Duan","year":"2008","unstructured":"Duan L, Wu AH, Sullivan-Halley J, Bernstein L. Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric adenocarcinomas in Los Angeles County. Cancer Epidemiology and Prevention Biomarkers. 2008;17(1):126\u201334.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"8455_CR47","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1093\/aje\/kwp162","volume":"170","author":"M Epplein","year":"2009","unstructured":"Epplein M, Nomura AM, Wilkens LR, Henderson BE, Kolonel LN. Nonsteroidal antiinflammatory drugs and risk of gastric adenocarcinoma: the multiethnic cohort study. Am J Epidemiol. 2009;170(4):507\u201314.","journal-title":"Am J Epidemiol"},{"key":"8455_CR48","unstructured":"Humans IWGotEoCRt, Cancer IAfRo, Organization WH. Schistosomes, liver flukes and Helicobacter pylori. International Agency for Research on Cancer; 1994. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK487782\/."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-024-08455-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-024-08455-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-024-08455-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T10:04:21Z","timestamp":1726740261000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-024-08455-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,19]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["8455"],"URL":"https:\/\/doi.org\/10.1186\/s13063-024-08455-5","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,19]]},"assertion":[{"value":"7 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol, informed consent forms, and recruitment materials were reviewed and endorsed by the Ardabil University of Medical Sciences Ethics Committee (reference number: IR.ARUMS.REC.1395.135, the updated version: IR.ARUMS.REC.1403.179) for their scientific content and compliance with research and human subject regulations. Prior to any study-related procedures, a study physician will obtain written and signed informed consent from each participant.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There is no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"617"}}